Amryt Pharma plc (LON:AMYT – Get Rating) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 143 ($1.79) and traded as low as GBX 143 ($1.79). Amryt Pharma shares last traded at GBX 143 ($1.79), with a volume of 90,727 shares trading hands.
Amryt Pharma Price Performance
The firm has a market capitalization of £457.11 million and a price-to-earnings ratio of -4.33. The company has a fifty day moving average price of GBX 143 and a two-hundred day moving average price of GBX 143. The company has a quick ratio of 1.14, a current ratio of 1.80 and a debt-to-equity ratio of 66.05.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
- How to Calculate Stock Growth
- 7 Best Retail Stocks to Invest in
- 3 Home Improvement Stocks to Renovate Your Portfolio
- Beam Global Shines Brightly in the EV Infrastructure Space
- Canoo Bottoms As Production Ramp Gets Closer
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.